Regulatory clearance fuels global growth of award-winning micro-needling device
DALLAS, April 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, is pleased to announce clearance by Health Canada for the the Eclipse MicroPen® Elite, an advanced medical-grade, automated, cordless, high-speed micro-needling device.
Clinics utilize the MicroPen® Elite to aid in the improved appearance of wrinkles, stretch marks, acne scars, skin tone and texture. The device can be used on various areas including the face, neck, décolleté, arms, hands and beyond.
“We’re excited to bring the Eclipse MicroPen® Elite to the Canadian market,” said Tom O’Brien, CEO and Founder of Eclipse. “The micro-needling pen’s popularity, reliability and clinical efficacy has been highly sought after by Canadian skin-care professionals at American medical conferences. For the first time, it can now be sold though our distribution partner Salient Medical Solutions.”
“Salient’s commitment to sourcing innovative and advanced medical technology continues with its alliance with Eclipse,” says Jay Herman, President of Salient Medical Solutions. “The micro-needling pen, company’s future innovations and commitment to regulatory compliance made our decision to partner with Eclipse clear.”
The automated micro-needling pen is a safe alternative to common skin resurfacing tools, such as lasers and dermal rollers. The MicroPen® Elite, which won THE Aesthetic Industry Award for “Best Micro-Needling Device,” is affordable, portable, effective, requires minimal to no down time and provides natural-looking results.
“With the Health Canada clearance and growing global distribution of Eclipse MicroPen® Elite, we look forward to reaching a new consumer base,” said Tom Goslau, Director of International Sales. “The device will allow skin-care providers a new and more effective way to address the evolving needs of aging consumers.” Read More